Patent 12264358
Litigation summary
Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.
Active provider: Google · gemini-2.5-pro
No PTAB proceedings on file. This patent has not been challenged through Inter Partes Review, Post-Grant Review, or Covered Business Method review at the USPTO. The absence is itself a signal — well-asserted patents eventually attract IPRs.
Cases on file (1)
Group view →Specific litigation cases in our database that name US patent 12264358. The free-form analysis below may also discuss cases beyond this list.
- 10x Genomics, Inc. et al. v. Element Biosciences, Inc.filed May 8, 2026U.S. District Court for the District of Delawarepending
Defendants: Element Biosciences, Inc.
Litigation summary
Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.
Litigation Involving US Patent 12,264,358
As of May 12, 2026, there is one known litigation case involving U.S. Patent No. 12,264,358.
Case Details:
- Plaintiffs: 10x Genomics, Inc. and President and Fellows of Harvard College (Harvard University)
- Defendant: Element Biosciences, Inc.
- Jurisdiction: U.S. District Court for the District of Delaware
- Case Number: Not yet publicly available.
- Filing Date: May 8, 2026
- Outcome or Current Status: This case was recently filed, and its current status is pending.
The lawsuit alleges that Element Biosciences' AVITI24 platform and Teton chemistry infringe upon U.S. Patent No. 12,264,358, along with U.S. Patent Nos. 11,021,737, 11,566,276, and 11,566,277. The plaintiffs are seeking a permanent injunction to block sales of the accused products or, alternatively, ongoing royalties for future infringement and damages for past infringement.
Generated 5/12/2026, 6:45:29 AM